AUM Biosciences is an oncology-focused biotechnology company. It develops highly selective targeted oncology therapeutics for the treatment of hepatocellular carcinoma, head and neck cancer, gastric cancer, cholangiocarcinoma, triple-negative breast cancer, as well as prostate and colorectal cancer.